Dark Forest Capital Management LP Viridian Therapeutics, Inc.\De Transaction History
Dark Forest Capital Management LP
- $634 Million
- Q4 2024
A detailed history of Dark Forest Capital Management LP transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Dark Forest Capital Management LP holds 13,285 shares of VRDN stock, worth $202,729. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,285Holding current value
$202,729% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding VRDN
# of Institutions
199Shares Held
79.2MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$72.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$70.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$69 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$59.3 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$53.8 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $609M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...